ESC Premium Access

Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica

Congress Presentation

About the speaker

Doctor Anselm Kai Gitt

Klinikum Ludwigshafen, Ludwigshafen (Germany)
15 presentations
0 follower

20 more presentations in this session

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Speaker: Doctor I. Dykun (Essen, DE)


Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence

Speaker: Doctor D. Huber (Umea, SE)


Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients

Speaker: Doctor Y. Kumada (Kasamatsu, JP)


The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris

Speaker: Doctor G. Svingen (Bergen, NO)


Post-prandial remnant lipoprotein metabolism in sitosterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)


Access the full session

Poster Session 6 - Preventive cardiology / Lipids

Speakers: Doctor A. Gitt, Doctor I. Dykun, Doctor D. Huber, Doctor Y. Kumada, Doctor G. Svingen...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb